Share Search
Visit the Share Search
Astrazeneca Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Revenue | 45,811.00 | 44,351.00 | 37,417.00 | 26,617.00 | 24,384.00 |
| Operating Profit / Loss | 8,193.00 | 3,757.00 | 1,056.00 | 5,162.00 | 2,924.00 |
| Net Interest | -1,282.00 | -1,251.00 | -1,257.00 | -1,219.00 | -1,260.00 |
| Pre Tax Profit | 6,899.00 | 2,501.00 | -265.00 | 3,916.00 | 1,548.00 |
| Post Tax Profit | 5,961.00 | 3,293.00 | 115.00 | 3,144.00 | 1,227.00 |
| Profit for the Period | 5,961.00 | 3,293.00 | 115.00 | 3,144.00 | 1,227.00 |
| Equity Holders of Parent Company | 5,955.00 | 3,288.00 | 112.00 | 3,196.00 | 1,335.00 |
| Minority Interests | 6.00 | 5.00 | 3.00 | -52.00 | -108.00 |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 384.00 USX | 212.00 USX | 8.00 USX | 244.00 USX | 103.00 USX |
| Earnings per Share (Diluted) | 381.00 USX | 211.00 USX | 8.00 USX | 244.00 USX | 103.00 USX |
| Earnings per Share (Adjusted) | 384.00 USX | 212.00 USX | 8.00 USX | 244.00 USX | 103.00 USX |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 384.00 USX | 212.00 USX | 8.00 USX | 244.00 USX | 103.00 USX |
| Earnings per Share (Diluted) | 381.00 USX | 211.00 USX | 8.00 USX | 244.00 USX | 103.00 USX |
| Earnings per Share (Adjusted) | 384.00 USX | 212.00 USX | 8.00 USX | 244.00 USX | 103.00 USX |
| Dividend per Share | 290.00 USD | 290.00 USD | 287.00 USD | 280.00 USD | 280.00 USD |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Non-Current Assets | |||||
| Intangible Assets | 58,137.00 | 59,127.00 | 62,384.00 | 32,792.00 | 32,501.00 |
| Property, Plant and Equipment | 10,502.00 | 9,449.00 | 10,171.00 | 8,917.00 | 8,335.00 |
| Investments | 1,677.00 | 1,142.00 | 1,237.00 | 1,147.00 | 1,459.00 |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | 5,749.00 | 4,172.00 | 5,327.00 | 4,329.00 | 3,519.00 |
| Total Non-Current Assets | 76,065.00 | 73,890.00 | 79,119.00 | 47,185.00 | 45,814.00 |
| Current Assets | |||||
| Inventories | 5,424.00 | 4,699.00 | 8,983.00 | 4,024.00 | 3,193.00 |
| Trade and Other Receivables | 13,552.00 | 11,252.00 | 10,307.00 | 7,022.00 | 5,761.00 |
| Cash at Bank and in Hand | 5,840.00 | 6,166.00 | 6,329.00 | 7,832.00 | 5,369.00 |
| Current Asset Investments | 122.00 | 239.00 | 69.00 | n/a | 849.00 |
| Other Current Assets | 116.00 | 87.00 | 556.00 | 666.00 | 391.00 |
| Total Current Assets | 25,054.00 | 22,443.00 | 26,244.00 | 19,544.00 | 15,563.00 |
| Other Assets | n/a | 150.00 | n/a | n/a | n/a |
| Total Assets | 101,119.00 | 96,483.00 | 105,363.00 | 66,729.00 | 61,377.00 |
| Current Liabilities | |||||
| Borrowings | 5,400.00 | 5,542.00 | 1,893.00 | 2,386.00 | 2,010.00 |
| Other Current Liabilities | 25,142.00 | 20,751.00 | 20,701.00 | 17,921.00 | 16,107.00 |
| Total Current Liabilities | 30,542.00 | 26,293.00 | 22,594.00 | 20,307.00 | 18,117.00 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 23,222.00 | 23,690.00 | 28,888.00 | 17,994.00 | 16,217.00 |
| Provisions | 3,971.00 | 3,840.00 | 7,162.00 | 3,502.00 | 3,331.00 |
| Other Non-Current Liabilities | 4,218.00 | 5,602.00 | 7,432.00 | 9,288.00 | 9,116.00 |
| Total Non-Current Liabilities | 31,411.00 | 33,132.00 | 43,482.00 | 30,784.00 | 28,664.00 |
| Net Assets | 39,166.00 | 37,058.00 | 39,287.00 | 15,638.00 | 14,596.00 |
| Capital and Reserves | |||||
| Share Capital | 388.00 | 387.00 | 387.00 | 328.00 | 328.00 |
| Share Premium Account | 35,188.00 | 35,155.00 | 35,126.00 | 7,971.00 | 7,941.00 |
| Other Reserves | 2,065.00 | 2,069.00 | 2,045.00 | 2,024.00 | 2,046.00 |
| Retained Earnings | 1,502.00 | -574.00 | 1,710.00 | 5,299.00 | 2,812.00 |
| Shareholders Funds | 39,143.00 | 37,037.00 | 39,268.00 | 15,622.00 | 13,127.00 |
| Minority Interests / Other Equity | 23.00 | 21.00 | 19.00 | 16.00 | 1,469.00 |
| Total Equity | 39,166.00 | 37,058.00 | 39,287.00 | 15,638.00 | 14,596.00 |
| 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | |
| Operating Margin | 17.88% | 8.47% | 2.82% | 19.39% | 11.99% |
| Return on Capital Employed | 60.06% | 34.10% | 6.68% | 76.32% | 76.87% |
| Dividend Cover | 1.32 | 0.73 | 0.03 | 0.87 | 0.37 |
| Dividend Yield | 2.20 | 2.00 | 2.60 | 3.00 | 2.90 |
| PE Ratio | 34.80 | 66.80 | 1,368.80 | 37.90 | 93.20 |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | -1.03% | -2.44% | n/a% |
| Net Asset Value per Share | -12.24 USD | -14.24 USD | -14.90 USD | -11.07 USD | -11.55 USD |